Werewolf Therapeutics Inc (HOWL)
4.89
-0.11
(-2.20%)
USD |
NASDAQ |
May 22, 16:00
4.89
0.00 (0.00%)
After-Hours: 16:30
Werewolf Therapeutics Profit Margin (Quarterly): -2.18K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.18K% |
| December 31, 2023 | -799.7% |
| September 30, 2023 | -140.5% |
| June 30, 2023 | -63.09% |
| Date | Value |
|---|---|
| March 31, 2023 | -268.4% |
| December 31, 2022 | -163.8% |
| September 30, 2022 | -240.3% |
| June 30, 2022 | -351.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.18K%
Minimum
Mar 2024
-63.09%
Maximum
Jun 2023
-526.2%
Average
-254.4%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -14.54K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Protalix BioTherapeutics Inc | -122.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.78% |
| Return on Assets | -22.87% |
| Return on Invested Capital | -26.75% |
| Operating Margin (Quarterly) | -2.31K% |
| Return on Net Operating Assets | -210.6% |